Kezar Life Sciences Inc (KZR)
7.55
+0.01
(+0.13%)
USD |
NASDAQ |
Nov 14, 16:00
7.55
0.00 (0.00%)
After-Hours: 16:41
Kezar Life Sciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.0463 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0463
Minimum
Sep 2023
0.0463
Maximum
Sep 2023
0.0463
Average
0.0463
Median
Sep 2023
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 179.92M |
| Total Liabilities (Quarterly) | 29.24M |
| Shareholders Equity (Quarterly) | 150.68M |